We are live on
!
Find out more
SGYP
Synergy Pharmaceuticals, Inc Common Stock
SGYP
SGYP
Delisted
SGYP was delisted on the 7th of March, 2019.
149 hedge funds and large institutions have $542M invested in Synergy Pharmaceuticals, Inc Common Stock in 2016 Q3 according to their latest regulatory filings, with 30 funds opening new positions, 53 increasing their positions, 32 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
124% more call options, than puts
Call options by funds: $9.5M | Put options by funds: $4.24M
114% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 14
66% more repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 32
40% more capital invested
Capital invested by funds: $386M → $542M (+$156M)
11% more funds holding
Funds holding: 134 → 149 (+15)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Holders
149
Holders Change
+15
Holders Change %
+11.19%
% of All Funds
3.98%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
30
Increased
53
Reduced
32
Closed
14
Calls
$9.5M
Puts
$4.24M
Net Calls
+$5.26M
Net Calls Change
+$3.35M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$7.47M |
| 2 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$3.77M |
| 3 |
Morgan Stanley
New York
|
+$3.43M |
| 4 |
EI
EAM Investors
Solana Beach,
California
|
+$2.47M |
| 5 |
FI
Fosun International
Hong Kong,
China
|
+$2.37M |
Top Sellers
| 1 |
PC
Paulson & Co
New York
|
-$16.5M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$6.35M |
| 3 |
SG Americas Securities
New York
|
-$5.65M |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$5.47M |
| 5 |
Millennium Management
New York
|
-$4.53M |
